Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma

NCT02861690 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Carcinoma

Interventions

DRUG: Liposomal Paclitaxel
DRUG: Nedaplatin

Sponsor

Sun Yat-sen University